What Are Peptides, and What's the Hype
Jylamvo first won approval in November 2022 to treat adults with acute lymphoblastic leukemia, mycosis fungoides, relapsed or refractory non-Hodgkin lymphoma, rheumatoid arthritis and severe psoriasis
Scirica BM, Braunwald E, Raz I, Cavender MA, Morrow DA, Jarolim P, Udell JA, Mosenzon O, Im K, Umez-Eronini AA, Pollack PS, Hirshberg B, Frederich R, Lewis BS, McGuire DK, Davidson J, Steg PG, Bhatt DL
Rev md Chile [Internet]
H.et al (2023b)
Elevated anterior cingulate cortex (ACC) glutamate has been found to be inversely correlated with striatal dopamine synthesis in patients with FEP [10]